Neurological acute stroke care: The role of European neurology European Federation of Neurological Societies Task Force

European Journal of Neurology

Volumn 4, Issue 5, 1997, Pages 435-441

  Brainin, Michael ^a  

^a DANUBE UNIVERSITY KREMS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

EUROPE; HOSPITAL SERVICE; HUMAN; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; STROKE;

EID: 0030773740     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1997.tb00381.x     Document Type: Article

References (5)

1. Adams HP, Brott TG Crowell RM, Furlan AJ, Gomez, CR, Grotta J, Helgason, CM, Marier JR, Woolson RF, Zivin JA, Feinberg W and Mayberg M (1994) Guidelines for the management of patients with acute ischemic stroke. Stroke, 25, 1901-1914.
2. Canadian Cooperative Study Group (1978) A randomized trial of aspirin and sulfapyrazon in threatening stroke. New England Journal of Medicine, 299, 53-55.
3. Chinese Acute Stroke Trial Collaborative Group (1997) CAST: a randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 349, 1641-1649.
4. Davalos A, Castillo J and Martinez-Vila E (1995) Delay in neurological attention and stroke outcome. Stroke, 26, 2233-2237.
5. Davenport RJ, Dennis MS, Wellwood I and Warlow CP (1996) Complications after acute stroke. Stroke, 27, 415-420.